OOIR: Observatory of International Research

Papers

(The H4-Index of Archives of Pharmacal Research is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Mouse models of nonalcoholic steatohepatitis and their application to new drug development	199
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process	154
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity	77
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo	74
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation	62
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy	56
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities	53
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer	50
Impact of binge drinking on alcoholic liver disease	49
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats	47
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin	46
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions	43
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway	39
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways	39
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight	37
Germacrane and humulane sesquiterpenes from the roots and rhizomes of Valeriana officinalis var. latifolia and their anti-inflammatory and anti-influenza virus activities	36
Advances in plant-derived natural products for antitumor immunotherapy	35
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration	35
The role and application of transcriptional repressors in cancer treatment	34
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis	34
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes	32
Minor structural changes, major functional impacts: posttranslational modifications and drug targets	32
Non-alcoholic fatty liver disease and liver secretome	31
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis	31
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis	31

A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations	30
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes	29
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation	28